Mechanism of Action of Kerendia (Finerenone)
Introduction Kerendia is the brand name for finerenone, a non-steroidal selective mineralocorticoid receptor antagonist (MRA) used to reduce the risk of chronic kidney disease (CKD) progression and cardiovascular complications in adults with chronic kidney disease associated with type 2 diabetes mellitus. Unlike older steroidal MRAs such as spironolactone and eplerenone, finerenone has a unique non-steroidal … Read more